Congratulations to Procopio client Revolution Medicines, Inc. (Nasdaq: RVMD) on securing leases for around 672,000 square feet at Pacific Shores Center in Redwood City, California. This expansion nearly doubles their local presence, growing from 61,000 square feet in 2020 to approximately 293,000 square feet today.
Procopio’s Real Estate Partner, David Crawford, led the team advising Revolution Medicines, with assistance from Special Counsel Karli Joseph. This deal highlights Procopio’s expertise in navigating the complexities of real estate decisions for life sciences companies, especially in a challenging market.
Revolution Medicines is dedicated to transforming treatment for patients with RAS-addicted cancers through innovative targeted medicines. Recently, they achieved a significant milestone with the FDA’s approval of RASONQUE™ (daraxonrasib) for specific adult metastatic pancreatic cancer patients, marking their transition to a commercial-stage oncology company.
Pacific Shores Center sits on a 106-acre bayfront business park, previously an office hub for Google until 2024. Portions of this campus have been acquired by Farallon Capital Management, with Harvest Properties also moving to acquire buildings.
For further details, check out this news article.
